摘要
目的：探讨艾司西酞普兰联合莫沙比利在胃食管反流病患者中的应用及效果。方法：选取我院自2010年5月-2011年5月消化内科收治的90例胃食管反流病患者为研究对象,随机将其分为A组和B组,观察并比较患者的疗效和药物不良反应。结果：B组患者治疗总有效率显著高于A组的（95.56%vs 82.22%,P〈0.05）,两组患者均未见显著的药物不良反应出现。结论：艾司西酞普兰联合莫沙比利能够有效改善胃食管反流病患者的临床症状,且无显著的药物不良反应,安全高效。
Objective：To investigate the combined Mosa Billy of escitalopram in gastroesophageal reflux disease patients and its effect.Methods：In our hospital from 2010 May to 2011 May digestion Department of internal medicine treated 90 cases of patients with gastroesophageal reflux disease as the object of study,randomly divided into A group and B group,observe and compare the curative effect and adverse drug reaction.Results：The patients in the B group total effective rate （95.56%） was significantly higher than that in A group （82.22%）,the total efficiency of the differences were statistically significant （P〈0.05）,two groups of patients had no obvious adverse drug reaction.Conclusion：Citalopram combined with Mosa Billy can effectively improve gastroesophageal reflux disease in patients with clinical symptoms,and no obvious adverse drug reaction,safety and high efficiency.
出处
《中国医药导刊》
2014年第2期256-256,258,共2页
Chinese Journal of Medicinal Guide
关键词
艾司西酞普兰
莫沙比利
胃食管反流病
临床疗效
Escitalopram
Moshabili
Gastroesophageal reflux disease
Clinical curative effect
